# Grifols Therapeutics LLC - Inspection Records Source: https://www.keypedia.com/companies/grifols-therapeutics-llc/2e4dd489-4e70-4ef7-a1f8-f0267f91fab5 > Inspection records and compliance data for Grifols Therapeutics LLC in Clayton, North Carolina. Access full analysis and detailed observations. --- ## Details - Name: Grifols Therapeutics LLC - FEI Number: 1050373 - City: Clayton - State: North Carolina - Country Name: United States - Address Line 1: 8368 Us 70 Bus Hwy W - Zip Code: 27520 ## Related Documents - [483 - Grifols Therapeutics LLC - Unknown Date](https://www.keypedia.com/records/483/grifols-therapeutics-llc/179dc664-3ece-4464-a4cb-445c085a3e16) — source: FDA, date: Invalid Date - [483 - Grifols Therapeutics LLC - Unknown Date](https://www.keypedia.com/records/483/grifols-therapeutics-llc/9b3fca0f-5880-4793-ac91-143400fc36bf) — source: FDA, date: Invalid Date - [483 - Grifols Therapeutics LLC - Unknown Date](https://www.keypedia.com/records/483/grifols-therapeutics-llc/7dbd0e3f-4f85-4319-b54c-fcbb5a82d5d4) — source: FDA, date: Invalid Date - [483 - Grifols Therapeutics LLC - 2026-02-05](https://www.keypedia.com/records/483/grifols-therapeutics-llc/f00000c6-d7fa-4773-9efc-0d7051024010) — source: FDA, date: February 5, 2026 - [FDA Inspection 1302186 - Grifols Therapeutics LLC - 2026-02-05](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/34708a56-41e8-4e87-bab0-c702d71a2713) — source: FDA, date: February 5, 2026 - [483 - Grifols Therapeutics LLC - 2023-09-01](https://www.keypedia.com/records/483/grifols-therapeutics-llc/a0027827-e11c-4401-8d9e-736ea37fded6) — source: FDA, date: September 1, 2023 - [FDA Inspection 1221101 - Grifols Therapeutics LLC - 2023-09-01](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/8955f0eb-74f7-40f8-be3a-2ebaa64a50c8) — source: FDA, date: September 1, 2023 - [483 - Grifols Therapeutics LLC - 2022-05-06](https://www.keypedia.com/records/483/grifols-therapeutics-llc/d4734f09-a3e5-4c43-91a5-d5af64a9f8d4) — source: FDA, date: May 6, 2022 - [EIR - Grifols Therapeutics LLC - 2022-05-06](https://www.keypedia.com/records/eir/grifols-therapeutics-llc/669ab472-596a-4a2d-9260-1418fe0eb8cd) — source: FDA, date: May 6, 2022 - [FDA Inspection 1176467 - Grifols Therapeutics LLC - 2022-05-06](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/22e93194-bc84-49e1-8de7-445532cdee68) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 6, 2022 - [FDA Inspection 1176467 - Grifols Therapeutics LLC - 2022-05-06](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9cf52920-d34b-4f87-840d-e52213631e5a) — classification: No Action Indicated (NAI), source: FDA, date: May 6, 2022 - [483 - Grifols Therapeutics LLC - 2018-12-13](https://www.keypedia.com/records/483/grifols-therapeutics-llc/f336deae-08c7-4cf7-9256-f71f7bf699a9) — source: FDA, date: December 13, 2018 - [EIR - Grifols Therapeutics LLC - 2018-12-13](https://www.keypedia.com/records/eir/grifols-therapeutics-llc/32fb0695-4a70-4b07-8eb5-312e0f5fbac0) — source: FDA, date: December 13, 2018 - [FDA Inspection 1079999 - Grifols Therapeutics LLC - 2018-12-13](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/a8c4df93-a1d3-415f-a6ee-5067a6f6675c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2018 - [483 - Grifols Therapeutics LLC - 2016-10-21](https://www.keypedia.com/records/483/grifols-therapeutics-llc/e52d20cd-cb5a-4136-b15c-0bb2a128c9ec) — source: FDA, date: October 21, 2016 - [FDA Inspection 994781 - Grifols Therapeutics LLC - 2016-10-21](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/9a41f385-bd40-454e-bfcf-1cf95a896584) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 21, 2016 - [FDA Inspection 879629 - Grifols Therapeutics LLC - 2014-04-01](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/3819503a-012b-4527-ae84-c8ec0475194b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 1, 2014 - [FDA Inspection 710839 - Grifols Therapeutics LLC - 2011-01-13](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/a4a36dd2-9593-4264-b588-e61307d1a665) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2011 - [FDA Inspection 599585 - Grifols Therapeutics LLC - 2009-04-24](https://www.keypedia.com/records/fda_inspections/grifols-therapeutics-llc/e2632ef9-1afb-4ddb-b516-29626988cf84) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 24, 2009 ## Related Companies - [ABRYL LABORATORIES PRIVATE LIMITED](https://www.keypedia.com/companies/abryl-laboratories-private-limited/2c82dd5b-3db2-4630-9c9c-45113aa3d31f) - [Eco Lips, Inc.](https://www.keypedia.com/companies/eco-lips-inc/42df0992-5d1d-4dd5-b8b9-110b0d5fff88) - [BioMylz Pvt. Ltd.](https://www.keypedia.com/companies/biomylz-pvt-ltd/58a2681b-f475-4556-b06e-cd96db1b3d20) - [Zile Bonbons Ag](https://www.keypedia.com/companies/zile-bonbons-ag/1135877a-589a-43f1-9ec9-42f9ca1553cd) - [Profounda Inc](https://www.keypedia.com/companies/profounda-inc/f0b0632c-a673-4003-926f-00af86a7b53e) - [Linde Gas & Equipment Inc.](https://www.keypedia.com/companies/linde-gas-equipment-inc/796daf9f-80a4-495a-b2ae-aa46d3d9ae73) - [Innocore Sales & Marketing Inc.](https://www.keypedia.com/companies/innocore-sales-marketing-inc/a07a64a3-3870-4c22-ae98-196920c049b0) - [WIZCURE PHARMAA PRIVATE LIMITED](https://www.keypedia.com/companies/wizcure-pharmaa-private-limited/7ddaac90-981c-4180-9174-423cfa950bc5) - [Nippon Shikizai, Inc.](https://www.keypedia.com/companies/nippon-shikizai-inc/252cb221-d383-4603-b0ec-18e8cac34e32) - [Yangzhou H&R Plastic Daily Chemical Co., Ltd.](https://www.keypedia.com/companies/yangzhou-hr-plastic-daily-chemical-co-ltd/82d1d0d7-d678-4540-9d65-98fb1cf5dbcb) ## Related Officers - [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001) - [Laurel A. Beer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e) - [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb) - [company_representative](https://www.keypedia.com/people/sergi-roura/2757463d-6b0b-4d9b-bffd-e39700889ae6)